These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7727966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
    Handa M, Ikeda Y, Kurata Y, Tsubaki K, Horiuchi A, Furihata K, Kimura Y, Toyama K, Takamoto S, Tsukimoto I.
    Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
    [Abstract] [Full Text] [Related]

  • 3. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM, Wollenhaupt HJ, Brüster HT.
    Beitr Infusionsther; 1991 Apr; 28():209-12. PubMed ID: 1725621
    [Abstract] [Full Text] [Related]

  • 4. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, Mezzano D.
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ, Bradley BA, Rees BM, Younie M, Hows JM.
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
    Snyder EL.
    Yale J Biol Med; 1990 Jun; 63(5):419-27. PubMed ID: 2293501
    [Abstract] [Full Text] [Related]

  • 15. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
    Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A.
    Blood; 1995 Feb 01; 85(3):824-8. PubMed ID: 7833483
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O, Shirey RS, Goble-Lee M, Houp J, Zachary A, King KE, Ness PM.
    Transfusion; 2006 May 01; 46(5):754-6. PubMed ID: 16686842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
    Sniecinski I, O'Donnell MR, Nowicki B, Hill LR.
    Blood; 1988 May 01; 71(5):1402-7. PubMed ID: 3282572
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.